Navigation Links
Cequent Names Ted Hibben Chief Business Officer
Date:1/12/2009

CAMBRIDGE, Mass., Jan. 12 /PRNewswire/ -- Cequent Pharmaceuticals, a pioneer in the development of novel products to deliver RNAi-based treatments to prevent and treat human disease, announced that Ted Hibben has joined the company as chief business officer. Mr. Hibben comes to Cequent from Coley Pharmaceutical Group, where he was most recently vice president of business development and alliance management and played a key role in the company's $233 million acquisition by Pfizer in 2008. Coley was a publicly traded biopharmaceutical company specializing in vaccine adjuvant technology and a new class of immunomodulatory drug candidates designed to fight cancers, asthma, infectious diseases, and autoimmune diseases.

"Strategic partners have been key to Cequent's success to date and will become even more important as we continue to move our tkRNAi technology from the laboratory into clinical development against multiple diseases. Ted brings to Cequent a wealth of experience orchestrating a full range of strategic collaborations with leading pharmaceutical and biotech companies - from drug discovery, research, and clinical-development partnerships to licensing agreements," said Cequent President and CEO, Peter Parker. "Beyond his role in the Pfizer acquisition, Ted's recent track record includes closing nearly a dozen alliances totaling $750 million of itemized pre-commercial development milestones with companies like Novartis, GSK, and Merck."

Regarding Mr. Hibben's role at Cequent, Mr. Parker said, "Ted will focus on external partnering activities in three major areas. On our inflammatory bowel disease (IBD) program, he will look for partner(s) to further develop one or more of the 11 targets we are working on for Crohn's disease and ulcerative colitis; he will also seek to partner our CEQ508 candidate for FAP, slated for a Phase I clinical trial in 2009. FAP (familial adenomatous polyposis) is an inherited precursor to
'/>"/>

SOURCE Cequent Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Two Luminaries Join Cequent Scientific Advisory Board: Judy Lieberman, M.D. Ph.D., and Patrice Courvalin, M.D.
2. Cequent Pharmaceuticals Meets Novartis Option Fund Milestone; Continues to Next Phase to Validate Inflammatory Bowel Disease Targets in Vivo
3. Michael D. Taylor, Ph.D., Joins Cequent Pharmaceuticals Board of Directors
4. Clarus Ventures Names Two New Partners
5. Xceleron Names Michael Butler as President & CEO
6. Genome Technology Names 2008 Tomorrows PIs
7. Octapharma Names Dennis D. Curtin To Lead U.S. Plasma Operations
8. USP Names Matthew Heyman Vice President of External Affairs and Strategic Integration
9. LCA-Vision Names Michael J. Celebrezze CFO
10. Wyeth Names Michael Kamarck President, Technical Operations & Product Supply
11. Great Basin Scientific, Inc. Names Laurence Rea as Vice President of Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... -- Health eCareers, the only online single-source healthcare recruiting ... announced the launch of ENA Job Center , ... ENA Job Center provides a powerful venue for the ... openings and for employers to reach the widest possible ... field. Job seekers now have a ...
(Date:3/6/2015)... 6, 2015   InspireMD, Inc. (NYSE MKT: NSPR) ... announced today that it will release its full financial results ... on Thursday, March 12 th after market close, followed ... its financial results and business outlook. Participants should ... (412) 542-4135 (International) and request the InspireMD call. A live ...
(Date:3/6/2015)... St. Paul, Minn. (PRWEB) March 06, 2015 ... cutting edge Scientific Symposia sessions for the grain ... call for abstracts. , 2015 marks the ... holding its Centennial Meeting in Minneapolis, Minnesota, U.S.A. ... forward-thinking presentations from international researchers who are looking ...
(Date:3/6/2015)... Global Specimen Solutions, Inc. ( ... specimen management and informatics, announced today that Series ... Inc. is excited to catapult our growing momentum ... further enhance our proprietary informatics tools and infrastructure ... GSS has proved rapid market uptake of our ...
Breaking Biology Technology:Health eCareers Announces Online Career Center for the Emergency Nurses Association 2Health eCareers Announces Online Career Center for the Emergency Nurses Association 3InspireMD to Report Financial Results for the Fourth Quarter and Year Ended December 31, 2014 on Thursday, March 12th 2AACCI Unveils Scientific Symposia Sessions for Centennial Meeting 2Global Specimen Solutions, Inc. Closes Series A Funding 2Global Specimen Solutions, Inc. Closes Series A Funding 3
... in Primary Hypercholesterolemia ... ... Genzyme Corp.,(Nasdaq: GENZ ) today announced the launch ... Cholestagel is a new, non-absorbed,cholesterol-lowering agent aimed at treating patients ...
... Oct. 23 Arbios Systems, Inc.,(OTC: ABOS) today ... agreement with NxStage Medical, Inc., whereby NxStage will,manufacture ... for use,in treating liver failure. Arbios is currently ... to begin a controlled pivotal clinical,trial for SEPET(TM). ...
... of Murder and a Wrong Should be put ... a Pardon" Giovanni Di Stefano, ROME, October 23 Giovanni ... Dr. Hawley Harvey Crippen. In,a letter supported by Dr John Trestrail ... the Secretary of State for,the pardon to be ,effective forthwith notwithstanding ...
Cached Biology Technology:Genzyme Launches Cholestagel(R) in Europe 2Genzyme Launches Cholestagel(R) in Europe 3Genzyme Launches Cholestagel(R) in Europe 4Genzyme Launches Cholestagel(R) in Europe 5Arbios Announces SEPET(TM) Manufacturing Agreement With NxStage Medical 2Arbios Announces SEPET(TM) Manufacturing Agreement With NxStage Medical 3Arbios Announces SEPET(TM) Manufacturing Agreement With NxStage Medical 4
(Date:2/5/2015)... PARK, N.C. , Feb. 5, 2015  Marken ... specialist logistics company and has launched a new marketing ... Clinical Logistics Organization (CLO).  The new campaign focuses on ... on patient, protocol and shipments. The first ... , aligns Marken,s priorities with its client,s priorities. ...
(Date:2/5/2015)... -- New Market Research Reports Title Global ... 2020 has Been Added to GrandViewReseach.com Report Database ... reach USD 5.10 billion by 2020, according to a ... help identify the site of tissue damage in case ... in medical imaging applications. They have been extensively used ...
(Date:2/5/2015)... 3, 2015 Despite a lack of ... such as consumer electronics, automotive, storage and telecommunication ... technology (SMT) screen printers. Innovations in electronics and ... push the adoption curve up. Meanwhile, sale volumes ... glue dispensers are indispensable in the production of ...
Breaking Biology News(10 mins):Marken Launches New Patient-Centric Campaign 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 3End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 2End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 3
... A high-speed chase across the Panama Canal in a Boston ... filmbut the protagonist of this story brandishes a butterfly net ... at the Smithsonian Tropical Research Institute. , "Our ... drives Sulfur butterfly migrations," said Robert Srygley, former Smithsonian post ...
... attention to National Child Health Day (today), the Preventive Cardiovascular ... consumer survey and launched a campaign to educate families about ... The national survey revealed that more than three in ... heart disease do not begin until adulthood. ...
... SAN DIEGO A Henry Ford Hospital study has identified ... of the most deadly cancers responsible for 2.1 percent of ... only 33 genes were reported associated with head and neck ... and neck-specific gene targets, opening the door to promising new ...
Cached Biology News:Panama butterfly migrations linked to El Niño, climate change 2Americans concerned about heart health, but not proactive enough to prevent it 2Study finds 231 new genes associated with head and neck cancer 2
This modular benchtop fume hood ventilates and purifies chemical fumes, allowing safe indoor release of exhaust. Bonded charcoal filters remove most organic contaminants. Options include final HEPA f...
... Tracker Intracellular Localization Kit with TransIT-siQUEST ... approach to directly label and deliver ... efficient yet non-destructive manner, for in ... functional inhibition of target gene expression ...
... mass numbers as a trigger, precisely isolates ... investigation and research of natural compounds. Key ... preparative operation. Switching between modes is simple ... support provides a quick solution for chemists ...
... Label IT siRNA Tracker Intracellular Localization Kit ... label and deliver siRNA, of your design, ... in vitro tracking experiments. Subcellular localization and ... be monitored following introduction of the labeled ...
Biology Products: